Biofrontera Inc. (BFRIW)
0.08
-0.04 (-33.33%)
At close: Jan 14, 2025, 9:00 PM
0.07
-5.26%
After-hours Jan 15, 2025, 12:09 PM EST
undefined% (undefined)
| Bid | 0.05 |
| Market Cap | 8.14M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.296 |
| PE Ratio (ttm) | -0.06 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.09 |
| Volume | 12,505 |
| Avg. Volume (20D) | 0 |
| Open | 0.08 |
| Previous Close | 0.12 |
| Day's Range | 0.06 - 0.08 |
| 52-Week Range | 0.06 - 0.08 |
| Beta | undefined |
About BFRIW
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also provides Xe...
Sector Healthcare
IPO Date n/a
Employees 83
Stock Exchange NASDAQ
Ticker Symbol BFRIW
Website https://www.biofrontera-us.com